Sodium Oligomannate for Mild-to-Moderate Alzheimer Dementia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Alzheimer's Research &Therapy
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A 36-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Trial of Sodium Oligomannate for Mild-to-Moderate Alzheimer's Dementia
Alzheimers Res Ther 2021 Mar 17;[EPub Ahead of Print], S Xiao, P Chan, T Wang, Z Hong, S Wang, W Kuang, J He, X Pan, Y Zhou, Y Ji, L Wang, Y Cheng, Y Peng, Q Ye, X Wang, Y Wu, Q Qu, S Chen, S Li, W Chen, J Xu, D Peng, Z Zhao, Y Li, J Zhang, Y Du, W Chen, D Fan, Y Yan, X Liu, W Zhang, B Luo, W Wu, L Shen, C Liu, P Mao, Q Wang, Q Zhao, Q Guo, Y Zhou, Y Li, L Jiang, W Ren, Y Ouyang, Y Wang, S Liu, J Jia, N Zhang, Z Liu, R He, T Feng, W Lu, H Tang, P Gao, Y Zhang, L Chen, L Wang, Y Yin, Q Xu, J Xiao, L Cong, X Cheng, H Zhang, D Gao, M Xia, T Lian, G Peng, X Zhang, B Jiao, H Hu, X Chen, Y Guan, R Cui, Q Huang, X Xin, H Chen, Y Ding, J Zhang, T Feng, M Cantillon, K Chen, JL Cummings, J Ding, M Geng, Z ZhangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.